{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:42:23Z","timestamp":1774053743066,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aims to use a novel technology based on natural language processing (NLP) to extract clinical information from electronic health records (EHRs) to characterise the clinical profile of patients diagnosed with spondyloarthritis (SpA) at a large-scale hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An observational, retrospective analysis was conducted on EHR data from all patients with SpA (including psoriatic arthritis (PsA)) at Hospital Universitario La Paz, between 2020 and 2022. Data were collected using Savana Manager, an NLP-based system, enabling the extraction of information from unstructured, free-text EHRs. Variables analysed included demographic data, SpA subtypes, comorbidities and treatments. The performance of the technology in detecting SpA clinical entities was evaluated through precision, recall and F-1 score metrics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From a hospital population of 639\u2009474 patients, 4337 (0.7%) patients had a diagnosis of SpA or their subtypes in their EHR. The population predominantly comprised men (55.3%) with a mean age of 50.9 years. Peripheral SpA (including PsA) was reported in 31.6%, axial SpA in 20.9%, both axial and peripheral SpA in 3.7%, while 43.7% of patients did not have the SpA subtype reported. Common comorbidities included hypertension (25.0%), dyslipidaemia (22.2%) and diabetes mellitus (15.5%). The use of conventional disease-modifying antirheumatic drugs (csDMARDs) and biological DMARDs (bDMARDs) was documented, with methotrexate (25.3% of patients) being the most used csDMARDs and adalimumab (10.6% of patients) the most used bDMARD. The NLP technology demonstrated high precision and recall, with all the assessed F-1 score values over 0.80, indicating reliable data extraction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The application of NLP technology facilitated the characterisation of the SpA patient profile, including demographics, clinical features, comorbidities and treatments. This study supports the utility of NLP in enhancing the understanding of SpA and suggests its potential for improving patient management by extracting meaningful information from unstructured EHR data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-004302","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:30:10Z","timestamp":1716593410000},"page":"e004302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Natural language processing to identify and characterize spondyloarthritis in clinical practice"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-5330","authenticated-orcid":false,"given":"Diego","family":"Benavent","sequence":"first","affiliation":[{"name":"Savana Research S.L, Madrid, Spain"},{"name":"Rheumatology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-748X","authenticated-orcid":false,"given":"Mar\u00eda","family":"Benavent-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Savana Research S.L, Madrid, Spain"},{"name":"Nutrition Department, CEU San Pablo Monteprincipe School, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-4427","authenticated-orcid":false,"given":"Judith","family":"Marin-Corral","sequence":"additional","affiliation":[{"name":"Savana Research S.L, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3852-4092","authenticated-orcid":false,"given":"Javier","family":"Arias-Manj\u00f3n","sequence":"additional","affiliation":[{"name":"Medsavana S.L, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-852X","authenticated-orcid":false,"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2446-186X","authenticated-orcid":false,"given":"Miren","family":"Taberna","sequence":"additional","affiliation":[{"name":"Savana Research S.L, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Medsavana S.L, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6953-409X","authenticated-orcid":false,"given":"Diana","family":"Peiteado","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2551","authenticated-orcid":false,"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[{"name":"Instituto de Salud Musculoesquel\u00e9tica, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-1964","authenticated-orcid":false,"given":"Eugenio","family":"de Miguel","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"2025090313111716000_10.2.e004302.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"2025090313111716000_10.2.e004302.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210747"},{"key":"2025090313111716000_10.2.e004302.3","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(73)90035-8"},{"key":"2025090313111716000_10.2.e004302.4","unstructured":"Classification of axial Spondyloarthritis inception cohort. ClinicalTrials.gov. Available: https:\/\/clinicaltrials.gov\/study\/NCT03993847 [Accessed 5 Jan 2024]."},{"key":"2025090313111716000_10.2.e004302.5","doi-asserted-by":"crossref","unstructured":"Poddubnyy D , Baraliakos X , Van den Bosch F , et al . Axial involvement in psoriatic arthritis cohort (AXIS): the protocol of a joint project of the assessment of spondyloarthritis international society (ASAS) and the group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA). Ther Adv Musculoskelet Dis 2021;13. doi:10.1177\/1759720X211057975","DOI":"10.1177\/1759720X211057975"},{"key":"2025090313111716000_10.2.e004302.6","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.7861\/fhj.2021-0095","article-title":"Artificial intelligence in healthcare: transforming the practice of medicine","volume":"8","author":"Bajwa","year":"2021","journal-title":"Future Healthc J"},{"key":"2025090313111716000_10.2.e004302.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222626"},{"key":"2025090313111716000_10.2.e004302.8","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/rheumatology\/kead291","article-title":"AI am a rheumatologist: a practical primer to large language models for rheumatologists","volume":"62","author":"Venerito","year":"2023","journal-title":"Rheumatology"},{"key":"2025090313111716000_10.2.e004302.9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/rheumatology\/kez375","article-title":"Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology"},{"key":"2025090313111716000_10.2.e004302.10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.24869","article-title":"Development of a natural language processing system for extracting rheumatoid arthritis outcomes from clinical notes using the National rheumatology informatics system for effectiveness registry","volume":"75","author":"Humbert\u2010Droz","year":"2023","journal-title":"Arthritis Care & Research"},{"key":"2025090313111716000_10.2.e004302.11","doi-asserted-by":"crossref","DOI":"10.2196\/20492","article-title":"Assessing the performance of clinical natural language processing systems: development of an evaluation methodology","volume":"9","author":"Canales","year":"2021","journal-title":"JMIR Med Inform"},{"key":"2025090313111716000_10.2.e004302.12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103259","article-title":"Characteristics and prognosis of COVID-19 in patients with COPD","volume":"9","author":"Graziani","year":"2020","journal-title":"J Clin Med"},{"key":"2025090313111716000_10.2.e004302.13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Eur Respir J"},{"key":"2025090313111716000_10.2.e004302.14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41598-023-50762-5","article-title":"Predictive model for a second hip fracture occurrence using natural language processing and machine learning on electronic health records","volume":"14","author":"Larrainzar-Garijo","year":"2024","journal-title":"Sci Rep"},{"key":"2025090313111716000_10.2.e004302.15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206004","article-title":"Major adverse cardiovascular events in coronary type 2 diabetic patients: identification of associated factors using electronic health records and natural language processing","volume":"11","author":"Gonz\u00e1lez-Juanatey","year":"2022","journal-title":"J Clin Med"},{"key":"2025090313111716000_10.2.e004302.16","doi-asserted-by":"crossref","unstructured":"Benson T . Principles of health interoperability HL7 and SNOMED: Second Edition.2012:1\u2013316.","DOI":"10.1007\/978-1-4471-2801-4"},{"key":"2025090313111716000_10.2.e004302.17","unstructured":"UMLS metathesaurus - Snomedct_Us (SNOMED CT, US edition) - synopsis. Available: https:\/\/www.nlm.nih.gov\/research\/umls\/sourcereleasedocs\/current\/SNOMEDCT_US\/index.html [Accessed 14 Dec 2023]."},{"key":"2025090313111716000_10.2.e004302.18","unstructured":"WMA declaration of helsinki \u2013 ethical principles for medical research involving human subjects \u2013 WMA \u2013 the World Medical Association. Available: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/ [Accessed 15 Feb 2024]."},{"key":"2025090313111716000_10.2.e004302.19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.reuma.2017.06.009","article-title":"Prevalencia de enfermedades reum\u00e1ticas en poblaci\u00f3n adulta en espa\u00f1a (Estudio EPISER 2016). Objetivos Y metodolog\u00eda","volume":"15","author":"Seoane-Mato","year":"2019","journal-title":"Reumatolog\u00eda Cl\u00ednica"},{"key":"2025090313111716000_10.2.e004302.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"2025090313111716000_10.2.e004302.21","doi-asserted-by":"crossref","unstructured":"Passia E , Vis M , Coates LC , et al . Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther 2022;24. doi:10.1186\/s13075-021-02680-y","DOI":"10.1186\/s13075-021-02680-y"},{"key":"2025090313111716000_10.2.e004302.22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001681","article-title":"Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients","volume":"7","author":"Chimenti","year":"2021","journal-title":"RMD Open"},{"key":"2025090313111716000_10.2.e004302.23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002514","article-title":"Does gender influence outcome measures similarly in patients with Spondyloarthritis? Results from the ASAS-perSpA study","volume":"8","author":"Benavent","year":"2022","journal-title":"RMD Open"},{"key":"2025090313111716000_10.2.e004302.24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10067-020-05423-7","article-title":"Understanding the paradigm of non-radiographic axial spondyloarthritis","volume":"40","author":"Benavent","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025090313111716000_10.2.e004302.25","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-perspa study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"key":"2025090313111716000_10.2.e004302.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170520"},{"key":"2025090313111716000_10.2.e004302.27","doi-asserted-by":"crossref","first-page":"151938","DOI":"10.1016\/j.semarthrit.2021.12.007","article-title":"Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with ankylosing spondylitis","volume":"52","author":"Puche-Larrubia","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313111716000_10.2.e004302.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150721"},{"key":"2025090313111716000_10.2.e004302.29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.41164","article-title":"Nonsteroidal antiinflammatory drugs as potential disease\u2010modifying medications in axial spondyloarthritis","volume":"72","author":"Wang","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-004302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:11:23Z","timestamp":1756930283000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-004302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,24]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/rmdopen-2024-004302"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-004302","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}